Adele C. Oliva

Adele Oliva has been a health care investor for over 20 years, focusing on commercial stage medical technology, health care service and specialty therapeutic investments. She co-founded 1315 Capital in 2014 to establish a firm focused on health care growth investing, and it has since raised two funds and has over $500 million under management. She currently serves on the boards of Colorescience, Encore Dermatology, Innovative Health, NovaSom, Onkos Surgical and TELA Bio.